Additional file 11: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 1: Table S1. of Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells

Chang Liu (35901)
Yang Liu (4829)
Xiao-xi Xu (3424295)
Xin Guo (123593)
Guang-wei Sun (3424298)
Xiao-jun Ma (3424301)

July 2016

Primer pairs used for quantitative real-time PCR studies, including primer sequence, gene ID, and pr...

Additional file 2: Table S2A. of In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

Michela Bulfoni (3564743)
Lorenzo Gerratana (3564737)
Fabio Del Ben (3564749)
Stefania Marzinotto (3564740)
Marisa Sorrentino (3564746)
Matteo Turetta (3564752)
Giacinto Scoles (659304)
Barbara Toffoletto (3564728)
Miriam Isola (3564731)
Carlo Beltrami (3564734)
Carla Di Loreto (20344)
Antonio Beltrami (3560588)
Fabio Puglisi (20338)
Daniela Cesselli (298854)

March 2016

Presenting enumeration of different CD45neg subgroups, as assessed by FACS, in blood samples obtaine...

Additional file 9: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Table S5. Weighted scores of the metabolic gene candidates calculated by the AHP-based model. (DOCX ...

Additional file 5: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Figure S1. Migration and invasion assays of the five PCa cell lines. (A–B) Representative images and...

Additional file 1: of Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Archana Anantharaman (3543350)
Terence Friedlander (3543362)
David Lu (3543365)
Rachel Krupa (3543335)
Gayatri Premasekharan (3543338)
Jeffrey Hough (3543341)
Matthew Edwards (44866)
Rosa Paz (3543359)
Karla Lindquist (3543353)
Ryon Graf (257852)
Adam Jendrisak (3543347)
Jessica Louw (3543332)
Lyndsey Dugan (3543356)
Sarah Baird (3543344)
Yipeng Wang (9800)
Ryan Dittamore (3350099)
Pamela Paris (3543329)

September 2016

Sequencing read counts for 10 CTCs from two patients with metastatic bladder cancer undergoing NGS. ...

Additional file 7: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Figure S2. Functions of the differentially expressed genes in glucose and glycogen metabolism. These...

Additional file 1 of 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani (4710744)
Michael Hofman (4054939)
Tony Mulcahy (4710741)
Scott Williams (27584)
Declan Murphy (3480083)
Bimal Parameswaran (4710747)
Rodney Hicks (4054942)

December 2017

Table S1 Characteristics and modality based results in BCR patients. Table S2 Characteristics and mo...

Additional file 10: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Table S1D. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...

Additional file 4: Table S2. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Julie Earl (2278957)
Sandra Garcia-Nieto (3537179)
Jose Martinez-Avila (3537185)
José Montans (3537191)
Alfonso Sanjuanbenito (3537176)
Mercedes Rodríguez-Garrote (3537188)
Eduardo Lisa (3537167)
Elena Mendía (3537170)
Eduardo Lobo (3537182)
Núria Malats (135767)
Alfredo Carrato (135757)
Carmen Guillen-Ponce (3537173)

October 2015

Statistical analysis of overall survival with regard to the detection of CTC and mutant KRAS cfDNA i...

Additional file 5: of Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

Marcus Vetter (3422660)
Julia Landin (5997692)
Barbara Szczerba (5997695)
Francesc Castro-Giner (5659600)
Sofia Gkountela (191896)
Cinzia Donato (5997698)
Ilona Krol (5997701)
Ramona Scherrer (5997704)
Catharina Balmelli (5997707)
Alexandra Malinovska (5997710)
Alfred Zippelius (805066)
Christian Kurzeder (5997713)
Viola Heinzelmann-Schwarz (390410)
Walter Weber (5997716)
Christoph Rochlitz (190083)
Nicola Aceto (5997719)

November 2018

Table S4. Therapy evaluation in patients with circulating tumor cells. The table shows the types of ...

Additional file 1 of A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes

Rui Sun (177521)
Lingling Tan (6459059)
Xuan Ding (1319553)
Jun A (12474918)
Zhangzhi Xue (11663725)
Xue Cai (30372)
Sainan Li (155912)
Tiannan Guo (230314)

November 2023

Additional file 1: Table S1. Information of patients and samples. Table S2. The differentially expre...

Additional file 8: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Table S1B. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...

Additional file 5: Figure S3. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Julie Earl (2278957)
Sandra Garcia-Nieto (3537179)
Jose Martinez-Avila (3537185)
José Montans (3537191)
Alfonso Sanjuanbenito (3537176)
Mercedes Rodríguez-Garrote (3537188)
Eduardo Lisa (3537167)
Elena Mendía (3537170)
Eduardo Lobo (3537182)
Núria Malats (135767)
Alfredo Carrato (135757)
Carmen Guillen-Ponce (3537173)

October 2015

Estimated Survival Curves adjusted by sex and age using Cox regression for CTC and KRAS Mutant model...

Additional file 2: Figure S1. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Julie Earl (2278957)
Sandra Garcia-Nieto (3537179)
Jose Martinez-Avila (3537185)
José Montans (3537191)
Alfonso Sanjuanbenito (3537176)
Mercedes Rodríguez-Garrote (3537188)
Eduardo Lisa (3537167)
Elena Mendía (3537170)
Eduardo Lobo (3537182)
Núria Malats (135767)
Alfredo Carrato (135757)
Carmen Guillen-Ponce (3537173)

October 2015

Specificity of KRAS mutation assays (G12D, G12R and G12V) determined by ddPCR of KRAS mutant and WT ...

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 1: Table S1. of Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells

Chang Liu (35901)
Yang Liu (4829)
Xiao-xi Xu (3424295)
Xin Guo (123593)
Guang-wei Sun (3424298)
Xiao-jun Ma (3424301)

July 2016

Primer pairs used for quantitative real-time PCR studies, including primer sequence, gene ID, and pr...

Additional file 2: Table S2A. of In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

Michela Bulfoni (3564743)
Lorenzo Gerratana (3564737)
Fabio Del Ben (3564749)
Stefania Marzinotto (3564740)
Marisa Sorrentino (3564746)
Matteo Turetta (3564752)
Giacinto Scoles (659304)
Barbara Toffoletto (3564728)
Miriam Isola (3564731)
Carlo Beltrami (3564734)
Carla Di Loreto (20344)
Antonio Beltrami (3560588)
Fabio Puglisi (20338)
Daniela Cesselli (298854)

March 2016

Presenting enumeration of different CD45neg subgroups, as assessed by FACS, in blood samples obtaine...

Additional file 9: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Table S5. Weighted scores of the metabolic gene candidates calculated by the AHP-based model. (DOCX ...

Additional file 5: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Figure S1. Migration and invasion assays of the five PCa cell lines. (A–B) Representative images and...

Additional file 1: of Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Archana Anantharaman (3543350)
Terence Friedlander (3543362)
David Lu (3543365)
Rachel Krupa (3543335)
Gayatri Premasekharan (3543338)
Jeffrey Hough (3543341)
Matthew Edwards (44866)
Rosa Paz (3543359)
Karla Lindquist (3543353)
Ryon Graf (257852)
Adam Jendrisak (3543347)
Jessica Louw (3543332)
Lyndsey Dugan (3543356)
Sarah Baird (3543344)
Yipeng Wang (9800)
Ryan Dittamore (3350099)
Pamela Paris (3543329)

September 2016

Sequencing read counts for 10 CTCs from two patients with metastatic bladder cancer undergoing NGS. ...

Additional file 7: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Jing Chen (4762)
Shunwang Cao (5338076)
Bo Situ (4682563)
Juan Zhong (486982)
Yanwei Hu (766578)
Shufen Li (746508)
Jinlan Huang (4615594)
Jiasen Xu (729951)
Shiyang Wu (729947)
Jinduan Lin (5338073)
Qianwen Zhao (5467433)
Zhen Cai (576458)
Lei Zheng (106363)
Qian Wang (32718)

June 2018

Figure S2. Functions of the differentially expressed genes in glucose and glycogen metabolism. These...

Additional file 1 of 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani (4710744)
Michael Hofman (4054939)
Tony Mulcahy (4710741)
Scott Williams (27584)
Declan Murphy (3480083)
Bimal Parameswaran (4710747)
Rodney Hicks (4054942)

December 2017

Table S1 Characteristics and modality based results in BCR patients. Table S2 Characteristics and mo...

Additional file 10: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Table S1D. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...

Additional file 4: Table S2. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Julie Earl (2278957)
Sandra Garcia-Nieto (3537179)
Jose Martinez-Avila (3537185)
José Montans (3537191)
Alfonso Sanjuanbenito (3537176)
Mercedes Rodríguez-Garrote (3537188)
Eduardo Lisa (3537167)
Elena Mendía (3537170)
Eduardo Lobo (3537182)
Núria Malats (135767)
Alfredo Carrato (135757)
Carmen Guillen-Ponce (3537173)

October 2015

Statistical analysis of overall survival with regard to the detection of CTC and mutant KRAS cfDNA i...

Additional file 5: of Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

Marcus Vetter (3422660)
Julia Landin (5997692)
Barbara Szczerba (5997695)
Francesc Castro-Giner (5659600)
Sofia Gkountela (191896)
Cinzia Donato (5997698)
Ilona Krol (5997701)
Ramona Scherrer (5997704)
Catharina Balmelli (5997707)
Alexandra Malinovska (5997710)
Alfred Zippelius (805066)
Christian Kurzeder (5997713)
Viola Heinzelmann-Schwarz (390410)
Walter Weber (5997716)
Christoph Rochlitz (190083)
Nicola Aceto (5997719)

November 2018

Table S4. Therapy evaluation in patients with circulating tumor cells. The table shows the types of ...

Additional file 1 of A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes

Rui Sun (177521)
Lingling Tan (6459059)
Xuan Ding (1319553)
Jun A (12474918)
Zhangzhi Xue (11663725)
Xue Cai (30372)
Sainan Li (155912)
Tiannan Guo (230314)

November 2023

Additional file 1: Table S1. Information of patients and samples. Table S2. The differentially expre...

Additional file 8: of Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Tine Storebjerg (3468488)
Siri Strand (3468497)
Søren Høyer (3227682)
Anne-Sofie Lynnerup (3468491)
Michael Borre (130550)
Torben Ørntoft (3453632)
Karina Sørensen (3725155)

August 2018

Table S1B. Clinical characteristics for PC patients represented on the TMA. Data for RP patients for...

Additional file 5: Figure S3. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Julie Earl (2278957)
Sandra Garcia-Nieto (3537179)
Jose Martinez-Avila (3537185)
José Montans (3537191)
Alfonso Sanjuanbenito (3537176)
Mercedes Rodríguez-Garrote (3537188)
Eduardo Lisa (3537167)
Elena Mendía (3537170)
Eduardo Lobo (3537182)
Núria Malats (135767)
Alfredo Carrato (135757)
Carmen Guillen-Ponce (3537173)

October 2015

Estimated Survival Curves adjusted by sex and age using Cox regression for CTC and KRAS Mutant model...

Additional file 2: Figure S1. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Julie Earl (2278957)
Sandra Garcia-Nieto (3537179)
Jose Martinez-Avila (3537185)
José Montans (3537191)
Alfonso Sanjuanbenito (3537176)
Mercedes Rodríguez-Garrote (3537188)
Eduardo Lisa (3537167)
Elena Mendía (3537170)
Eduardo Lobo (3537182)
Núria Malats (135767)
Alfredo Carrato (135757)
Carmen Guillen-Ponce (3537173)

October 2015

Specificity of KRAS mutation assays (G12D, G12R and G12V) determined by ddPCR of KRAS mutant and WT ...

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 1: Table S1. of Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells

Chang Liu (35901)
Yang Liu (4829)
Xiao-xi Xu (3424295)
Xin Guo (123593)
Guang-wei Sun (3424298)
Xiao-jun Ma (3424301)

July 2016

Primer pairs used for quantitative real-time PCR studies, including primer sequence, gene ID, and pr...

Additional file 2: Table S2A. of In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

Michela Bulfoni (3564743)
Lorenzo Gerratana (3564737)
Fabio Del Ben (3564749)
Stefania Marzinotto (3564740)
Marisa Sorrentino (3564746)
Matteo Turetta (3564752)
Giacinto Scoles (659304)
Barbara Toffoletto (3564728)
Miriam Isola (3564731)
Carlo Beltrami (3564734)
Carla Di Loreto (20344)
Antonio Beltrami (3560588)
Fabio Puglisi (20338)
Daniela Cesselli (298854)

March 2016

Presenting enumeration of different CD45neg subgroups, as assessed by FACS, in blood samples obtaine...

Additional file 11: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Abstract

Extracted data

Additional file 11: of Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer

Abstract

Extracted data

Related items

Related items